secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001493152-23-045275
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX shareholders approve Juvenescence proposal allowing increased stake via preferred conversion
--------------------------------------------------------------------------------

- Juvenescence proposal approved: 18,908,391 for, 7,461,795 against, 38,095 abstain; 4.8M broker non-votes.
- Three directors re-elected: Bailey (18.6M for), Hackett (18.9M), Renondin (19.7M); broker non-votes 4.8M each.
- Auditor WithumSmith+Brown ratified: 23.5M for, 7.3M against, 496,875 abstain.
- Meeting held Dec 13, 2023; 82.36% of 37.95M shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223045275/0001493152-23-045275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223045275/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer